A plain language summary of the 5-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma
Saved in:
Published in | Future oncology (London, England) Vol. 19; no. 16; pp. 1091 - 1098 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.05.2023
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 1479-6694 1744-8301 |
---|---|
DOI: | 10.2217/fon-2022-1258 |